Published in
Elsevier, Annals of Oncology, 11(34), p. 1047-1054, 2023
DOI: 10.1016/j.annonc.2023.08.016
Links
Tools
EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma
Journal article published in 2023 by
J. E. Rosenberg,
T. Powles,
G. P. Sonpavde,
Y. Loriot,
I. Duran,
J.-L. Lee,
N. Matsubara,
C. Vulsteke 
,
D. Castellano,
R. Mamtani,
C. Wu,
M. Matsangou,
M. Campbell,
D. P. Petrylak
,
D. Castellano,
R. Mamtani,
C. Wu,
M. Matsangou,
M. Campbell,
D. P. Petrylak
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 